0001209191-14-003733.txt : 20140117
0001209191-14-003733.hdr.sgml : 20140117
20140117161737
ACCESSION NUMBER: 0001209191-14-003733
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140116
FILED AS OF DATE: 20140117
DATE AS OF CHANGE: 20140117
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEIDEN JEFFREY M
CENTRAL INDEX KEY: 0001242825
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 14535332
MAIL ADDRESS:
STREET 1: 40 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-01-16
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001242825
LEIDEN JEFFREY M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
1
0
0
CEO & President
Common Stock
2014-01-16
4
M
0
45000
29.98
A
227925
D
Common Stock
2014-01-16
4
S
0
45000
80.00
D
182925
D
Common Stock
440
I
401(k)
Stock Option
29.98
2014-01-16
4
M
0
45000
0.00
D
2021-12-13
Common Stock
45000
413108
D
Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.
The option vests in 16 quarterly installments from 12/14/2011.
Kenneth L. Horton, Attorney-In-Fact
2014-01-17